LHC Group Inc. (LHCG)

63.73
0.31 0.48
NASDAQ : Health Services
Prev Close 64.04
Open 64.03
Day Low/High 62.77 / 64.23
52 Wk Low/High 47.29 / 76.14
Volume 76.91K
Avg Volume 276.60K
Exchange NASDAQ
Shares Outstanding 18.29M
Market Cap 1.16B
EPS 2.10
P/E Ratio 27.19
Div & Yield N.A. (N.A)

Latest News

LHC Group And Erlanger Health System Finalize Joint Venture Agreement

LHC Group And Erlanger Health System Finalize Joint Venture Agreement

LHC Group (NASDAQ: LHCG) and Erlanger Health System today announced finalization of a new joint venture to enhance home health and community-based services in Chattanooga and southeast Tennessee.

LHC Group's CMS Star Ratings Again Exceed National Average

LHC Group's CMS Star Ratings Again Exceed National Average

In the latest Centers for Medicare & Medicaid Services (CMS) star ratings data - released in October - LHC Group, Inc.

LHC Group Reaches Analyst Target Price

In recent trading, shares of LHC Group Inc have crossed above the average analyst 12-month target price of $68.62, changing hands for $68.84/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

More Than 70 Percent Of LHC Group Home Care Locations Rank Among Nation's Best

More Than 70 Percent Of LHC Group Home Care Locations Rank Among Nation's Best

LHC Group, Inc. (NASDAQ: LHCG), a national provider of home health, hospice, and comprehensive post-acute healthcare services, saw more than two-thirds of its locations across the nation named among the nation's best as...

LHC Group And CHRISTUS Health Finalize Joint Venture Agreement

LHC Group And CHRISTUS Health Finalize Joint Venture Agreement

Effective Sept. 1, LHC Group (NASDAQ: LHCG) and CHRISTUS Health have finalized the formation of a joint venture partnership to enhance home health, hospice, community-based and long-term acute-care services across four...

Company Profile For LHC Group

Company Profile For LHC Group

LHC Group is a national provider of post-acute healthcare services - and the joint venture partner of choice for leading hospitals and health systems around the U.

LHC Group's CMS Star Ratings Continue To Lead Home Healthcare Industry

LHC Group's CMS Star Ratings Continue To Lead Home Healthcare Industry

LHC Group, Inc. (NASDAQ: LHCG) has again emerged as the top performer among national publicly traded home healthcare providers in the latest Centers for Medicare and Medicaid Services (CMS) Five-Star Quality Rating System...

LHC Group Second Quarter Earnings Per Diluted Share Increase 16.7% To $0.63 On 15.1% Growth In Revenue To $260.2 Million

LHC Group Second Quarter Earnings Per Diluted Share Increase 16.7% To $0.63 On 15.1% Growth In Revenue To $260.2 Million

Company Raises Fiscal Year 2017 Guidance for Fully Diluted Earnings Per Share to a Range of $2.30 to $2.40 and Net Service Revenue to a Range of $1.030 Billion to $1.045 Billion

LHC Group And CHRISTUS Health Announce Joint Venture Agreement

LHC Group And CHRISTUS Health Announce Joint Venture Agreement

LHC Group (NASDAQ: LHCG) and CHRISTUS Health today announced entry into a definitive agreement to form a new joint venture to enhance home health, hospice, long-term acute-care services and community-based services across...

LHCG Crosses Above Average Analyst Target

In recent trading, shares of LHC Group Inc have crossed above the average analyst 12-month target price of $63.57, changing hands for $63.60/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

LHC Group Reports First Quarter 2017 EPS Of $0.53 On Revenue Of $246.6 Million

Company Raises Fiscal Year 2017 Guidance for Fully Diluted Earnings Per Share to a Range of $2.23 to $2.33 and Net Service Revenue to a Range of $1.02 Billion to $1.04 Billion

LHCG Crosses Above Average Analyst Target

In recent trading, shares of LHC Group Inc have crossed above the average analyst 12-month target price of $55.43, changing hands for $55.70/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

LHCG Crosses Above Average Analyst Target

In recent trading, shares of LHC Group Inc have crossed above the average analyst 12-month target price of $51.67, changing hands for $53.10/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

TheStreet Quant Rating: A- (Buy)